A modular system to evaluate the efficacy of protease inhibitors against HIV-2.
The human immunodeficiency virus (HIV) protease is a homodimeric aspartyl protease that is crucial for the viral life-cycle, cleaving proviral polyproteins, hence creating mature protein components that are required for the formation of an infectious virus. With diagnostic measures and clinically us...
Main Authors: | Mohamed Mahdi, Krisztina Matúz, Ferenc Tóth, József Tőzsér |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4242608?pdf=render |
Similar Items
-
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
by: Mohamed Mahdi, et al.
Published: (2020-11-01) -
Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
by: János András Mótyán, et al.
Published: (2022-08-01) -
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
by: János András Mótyán, et al.
Published: (2022-03-01) -
Biochemical characterization of Ty1 retrotransposon protease.
by: Lívia Diána Gazda, et al.
Published: (2020-01-01) -
Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
by: Norbert Kassay, et al.
Published: (2021-02-01)